Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • Robert J. Motzer, MD (1)
Country
  • Argentina (1)
  • Bulgaria (1)
  • Canada (1)
  • Chile (1)
  • Czech Republic (1)
  • France (1)
  • Hungary (1)
  • India (1)
  • Italy (1)
  • Poland (1)
  • Romania (1)
  • Russian Federation (1)
  • Serbia (1)
  • Ukraine (1)
  • United Kingdom (1)
  • United States (1)
Source
  • nct (1)
Phase
  • complete (1)

Country: France,Czech Republic,Italy,United Kingdom,Russian Federation,Argentina - Phase: complete
Robert J. Motzer, MD Update Il y a 5 ans

A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma This is an open-label, randomized, controlled, multi-national, multi-center, parallel-arm trial comparing tivozanib to sorafenib in subjects with advanced RCC. The study is designed to compare the PFS, OS, ORR, DR, safety and tolerability, and kidney specific symptoms/health outcome measurements of tivozanib and sorafenib.

  • Country Argentina, Bulgaria, Canada, Chile, Czech Republic, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.